Normally distributed variables were described using the mean and standard deviation, while non-normally distributed variables were reported using the median and interquartile range
A reader should not interpret CareBareRX as a medication-specific GLP-1 provider or pharmacy
Key Takeaways Retatrutide (LY3437943) is an investigational triple hormone receptor agonist developed by Eli Lilly, acting at GIP, GLP-1, and glucagon receptors [1][3]
The difference between the two arms roughly six percentage points is the part attributable to the drug in that population
Lose up to 15% of your body weight with semaglutide, new & effective weight loss injections
If the Pen Is Damaged Discontinue use immediately if your pen is cracked, dropped hard enough to suspect internal damage, frozen, left in excessive heat (over 86F for extended periods), or otherwise compromised